JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2018, Vol. 32 ›› Issue (2): 99-102.doi: 10.6040/j.issn.1673-3770.0.2017.354

Previous Articles     Next Articles

Analysis of immunoglobulin G4-related ophthalmic disease associated with secondary glaucoma

XIE Hongbin, YANG Meina, CHEN Qingshan, LIU Xuyang, FAN Ning   

  1. Shenzhen Eye Hospital, Affiliated Shenzhen Eye Hospital of Jinan University, Joint College of Optometry of Shenzhen University, Shenzhen 518020, Guangdong, China
  • Received:2017-08-16 Online:2018-03-20 Published:2018-03-20

PDF (PC)

300

Abstract: Objective Immunoglobulin(Ig)G4-related disease has recently been recognized as a relatively rare systemic lesion with abnormal lymphocytes. IgG4-related disease can involve one or multiple organs, and is called IgG4-related ophthalmic disease(IgG4-ROD)when ocular tissue is involved. To analysis of IgG4-ROD associated with secondary glaucoma and to discuss its treatment method. Methods We analyzed clinical manifestations, biopsy, imaging examinations, the response to hormone therapy, and long-term observation. Results The serum IgG4 level is considered the most important serologic characteristic of the disease and has high diagnostic value but lacks specificity. Most patients respond to long-term glucocorticoid therapy, typically with symptomatic improvement, reductions in the size of masses or organ enlargement, improvement in organ function, and often a decrease in serum IgG4 levels. Conclusion Secondary glaucoma is one of the complications associated with IgG4-ROD, but there is still no consensus regarding the choice of surgical procedure, and the long-term postoperative outcome is unknown. It is important to recognize and address the complications of IgG4-ROD and the side effects associated with use of corticosteroids.

Key words: IgG4-related ophthalmic disease, Corticosteroid, Secondary glaucoma

CLC Number: 

  • R775.3
[1] Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome:analysis of 64 cases of IgG4-related disorders[J]. Ann Rheum Dis, 2009, 68(8):1310-1315.
[2] Takahashi H, Yamamoto M, Suzuki C, et al. The birthday of a new syndrome:IgG4-related diseases constitute a clinical entity[J]. Autoimmun Rev, 2010, 9(9):591-594.
[3] Smit WL, Culver EL, Chapman RW. New thoughts on immunoglobulin g4-related sclerosing cholangitis[J]. Clin Liver Dis, 2016, 20(1):47-65.
[4] Sa HS, Lee JH, Woo KI, et al. IgG4-related disease in idiopathic sclerosing orbital inflammation[J]. Br J Ophthalmol, 2015, 99(11):1493-1497.
[5] Leivo T, Koskenmies S, Uusitalo M, et al. IgG4-related disease mimicking chalazion in the upper eyelid with skin manifestations on the trunk[J]. Int Ophthalmol, 2015, 35(4):595-597.
[6] Kanari H, Kagami S, Kashiwakuma D, et al. Role of Th2 cells in IgG4-related lacrimal gland enlargement[J]. Int Arch Allergy Immunol, 2010, 152(Suppl 1):47-53.
[7] Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis:guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40(3):352-358.
[8] Mulay K, Aggarwal E, Jariwala M, et al. Orbital immunoglobulin-G4-related disease: case series and literature review[J]. Clin & Exper Ophthalmol, 2014, 42(7):682-687.
[9] Fukui M, Ogawa Y, Shimmura S, et al. Possible involvement of epithelial-mesenchymal transition in fibrosis associated with IgG4-related Mikuliczs disease[J]. Mod Rheumatol, 2015, 25(5):737-743.
[10] Mejico LJ. IgG4-related ophthalmic disease[J]. Saudi J Ophthalmol, 2015, 29(1):53-56.
[11] Soussan JB, Deschamps R, Sadik JC, et al. Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease:a specific sign[J]. Eur Radiol, 2017, 27(4):1335-1343.
[12] Sogabe Y, Ohshima K, Azumi A, et al. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases[J]. Graefes Arch Clin Exp Ophthalmol, 2014, 252(3):531-538.
[13] McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part I:background and pathology[J]. Ophthal Plast Reconstr Surg, 2015, 31(2):83-88.
[14] Behbehani RS, Al-Nomas HS, Al-Herz AA, et al. Bilateral intracranial optic nerve and chiasmal involvement in igg4-related disease[J]. J Neuroophthalmol, 2015, 35(2):229-231.
[15] Elner VM, Demirci H. IgG4-related orbital inflammation[M] // Orbital Inflammatory Diseases and Their Differential Diagnosis. London: Springer Berlin Heidelberg, 2015.
[16] Ohno K, Sato Y, Ohshima KI, et al. IgG4-related disease involving the sclera[J]. Mod Rheumatol, 2014, 24(1):195-198.
[17] Goto H, Takahira M, Azumi A, et al. Erratum to: Diagnostic criteria for IgG4-related ophthalmic disease[J]. Jpn J Ophthalmol, 2015, 59(3):201.
[18] Okazaki K, Umehara H. Are classification criteria for igg4-rd now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan[J]. Int J Rheumatol, 2012: 357071.
[19] Lu LX, Della-Torre E, Stone JH, et al. IgG4-related hypertrophic pachymeningitis:clinical features, diagnostic criteria, and treatment[J]. JAMA Neurol, 2014, 71(6):785-793.
[20] Yamamoto M, Awakawa T, Takahashi H. Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years[J]. Ann Rheum Dis, 2015, 74(8):46.
[21] 许晓. Ex-PRESS引流器植入术治疗青光眼的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(4):90-93. XU Xiao. Clinical observations of Ex-PRESS glaucoma filtration device implantation in patients with glaucoma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(4):90-93.
[1] CHEN Xi, LI Jin-rang. Meta analysis of nasal corticosteroid treatment in the children with obstructive sleep apnea hypopnea syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(2): 9-11.
[2] WANG Wei-zhi1, ZHANG Bing-feng2, LIU Shao-hua1, WANG Xin2. The clinical efficacy of systemic corticosteroids and thalidomide for oropharyngeal major recurrent aphthous ulcer [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(6): 72-73.
[3] XIE Li, WEI wei. Treatment progress of diabetic macular edema [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 81-85.
[4] ZHONG Zhao-tang, LIANG Min-zhi, CHEN Ze. Preferable treatment for nonspecific granuloma of larynx [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(1): 61-63.
[5] GUO Hui, WU Xin-yi. One case of viral cornea endotheliitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(2): 2-2.
[6] DING Feng-kui1, SU Wan-yuan2, LI Qiao-yun1, LI Chuan-bao2. Compound trabeculectomy on secondary glaucoma following anterior uveitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(5): 105-.
[7] LI Zhen. Effects of corticosteroid on expressions of HIF-1α and  VEGF in nasal polyps [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(1): 53-.
[8] YANG Jun1， SUN Yan1, ZHAO Jun1, HAN Jing-li2. Surgical treatment for secondary glaucoma  - in uveitis with cataract [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(5): 53-55.
[9] REN Xiu-min，ZHANG Yan，DUAN Nai-chao，YANG Yan-zhong. Effect of topical  corticosteroids  on  expression of aquaporin 8 in tissues of the nasal polyps [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(4): 45-47.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd